https://www.selleckchem.com/pr....oducts/Abiraterone.h
© 2020 International Society for Advancement of Cytometry.Background Patients with antiphospholipid antibodies (aPL) and thromboembolism (TE) are at risk for recurrent TE. Few studies, however, distinguish patients based on the initial event. Objectives We performed a systematic review and meta-analysis to investigate patients with aPL and venous TE (VTE), provoked or unprovoked, and patients with arterial TE (ATE). Patients/methods We conducted searches in PubMed, CINAHL, Cochrane, and EMBASE. Inclusion criteria were prospective tr
Like
Comment
Share
